These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
794 related items for PubMed ID: 8096875
1. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. Chaudhary PM, Roninson IB. J Natl Cancer Inst; 1993 Apr 21; 85(8):632-9. PubMed ID: 8096875 [Abstract] [Full Text] [Related]
2. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB. Proc Natl Acad Sci U S A; 1990 Sep 21; 87(18):7160-4. PubMed ID: 1976252 [Abstract] [Full Text] [Related]
3. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. Stein U, Walther W, Shoemaker RH. J Natl Cancer Inst; 1996 Oct 02; 88(19):1383-92. PubMed ID: 8827016 [Abstract] [Full Text] [Related]
4. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay. Ludescher C, Hilbe W, Eisterer W, Preuss E, Huber C, Gotwald M, Hofmann J, Thaler J. J Natl Cancer Inst; 1993 Nov 03; 85(21):1751-8. PubMed ID: 8105101 [Abstract] [Full Text] [Related]
5. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Chaudhary PM, Roninson IB. Oncol Res; 1992 Nov 03; 4(7):281-90. PubMed ID: 1360276 [Abstract] [Full Text] [Related]
6. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias. Beck JF, Brügger D, Brischwein K, Liu C, Bader P, Niethammer D, Gekeler V. Jpn J Cancer Res; 2001 Aug 03; 92(8):896-903. PubMed ID: 11509123 [Abstract] [Full Text] [Related]
7. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. Beketic-Oreskovic L, Durán GE, Chen KG, Dumontet C, Sikic BI. J Natl Cancer Inst; 1995 Nov 01; 87(21):1593-602. PubMed ID: 7563202 [Abstract] [Full Text] [Related]
8. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas. Holzmayer TA, Hilsenbeck S, Von Hoff DD, Roninson IB. J Natl Cancer Inst; 1992 Oct 07; 84(19):1486-91. PubMed ID: 1359152 [Abstract] [Full Text] [Related]
9. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1. Spitaler M, Utz I, Hilbe W, Hofmann J, Grunicke HH. Biochem Pharmacol; 1998 Oct 01; 56(7):861-9. PubMed ID: 9774148 [Abstract] [Full Text] [Related]
10. Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines. Frommel TO, Coon JS, Tsuruo T, Roninson IB. Int J Cancer; 1993 Sep 09; 55(2):297-302. PubMed ID: 8103760 [Abstract] [Full Text] [Related]
14. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. Herweijer H, Sonneveld P, Baas F, Nooter K. J Natl Cancer Inst; 1990 Jul 04; 82(13):1133-40. PubMed ID: 1972761 [Abstract] [Full Text] [Related]
15. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism. Bergman PJ, Gravitt KR, Ward NE, Beltran P, Gupta KP, O'Brian CA. Invest New Drugs; 1997 Jul 04; 15(4):311-8. PubMed ID: 9547673 [Abstract] [Full Text] [Related]
17. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. Park JG, Lee SK, Hong IG, Kim HS, Lim KH, Choe KJ, Kim WH, Kim YI, Tsuruo T, Gottesman MM. J Natl Cancer Inst; 1994 May 04; 86(9):700-5. PubMed ID: 7908989 [Abstract] [Full Text] [Related]
18. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G. Cancer Chemother Pharmacol; 1997 May 04; 40 Suppl():S13-9. PubMed ID: 9272128 [Abstract] [Full Text] [Related]
19. Expression of a multidrug resistance gene in human cancers. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM. J Natl Cancer Inst; 1989 Jan 18; 81(2):116-24. PubMed ID: 2562856 [Abstract] [Full Text] [Related]
20. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. Poupon MF, Arvelo F, Goguel AF, Bourgeois Y, Jacrot M, Hanania N, Arriagada R, Le Chevalier T. J Natl Cancer Inst; 1993 Dec 15; 85(24):2023-9. PubMed ID: 7902445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]